ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
0.061
0.001
(1.67%)
Cerrado 30 Enero 11:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.061
Postura de Compra
0.05
Postura de Venta
0.061
Volume Operado de la Acción
152,273
0.055 Rango del Día 0.061
0.038 Rango de 52 semanas 0.105
Capitalización de Mercado [m]
Precio Anterior
0.06
Precio de Apertura
0.06
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
131,306
Acciones en circulación
170,681,530
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.73
Beneficio por acción (BPA)
-0.03
turnover
6.34M
Beneficio neto
-5.91M

Acerca de Control Bionics Limited

Sector
Radiotelephone Communication
Industria
Radiotelephone Communication
Sede
Melbourne, Victoria, Aus
Fundado
-
Control Bionics Limited is listed in the Radiotelephone Communication sector of the Australian Stock Exchange with ticker CBL. The last closing price for Control Bionics was AUD0.06. Over the last year, Control Bionics shares have traded in a share price range of AUD 0.038 to AUD 0.105.

Control Bionics currently has 170,681,530 shares in issue. The market capitalisation of Control Bionics is AUD10.24 million. Control Bionics has a price to earnings ratio (PE ratio) of -1.73.

CBL Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.005-7.575757575760.0660.0660.0551082810.06027606DE
40.0011.666666666670.060.0660.0551090430.06276691DE
120.0011.666666666670.060.0670.0551313060.06238993DE
260.0058.928571428570.0560.1050.0551941460.07371001DE
520.01429.78723404260.0470.1050.0382628220.06122253DE
156-0.344-84.93827160490.4050.460.0331286200.08583105DE
260-1.059-94.55357142861.121.240.0331229190.30551443DE

CBL - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Control Bionics?
El precio actual de las acciones de Control Bionics es AUD 0.061
¿Cuántas acciones de Control Bionics están en circulación?
Control Bionics tiene 170,681,530 acciones en circulación
¿Cuál es la capitalización de mercado de Control Bionics?
La capitalización de mercado de Control Bionics es AUD 10.24M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Control Bionics?
Control Bionics ha negociado en un rango de AUD 0.038 a AUD 0.105 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Control Bionics?
El ratio precio/beneficio de Control Bionics es -1.73
¿Cuál es el ratio de efectivo a ventas de Control Bionics?
El ratio de efectivo a ventas de Control Bionics es 1.61
¿Cuál es la moneda de reporte de Control Bionics?
Control Bionics presenta sus resultados financieros en AUD
¿Cuál es el último ingresos anual de Control Bionics?
El último ingresos anual de Control Bionics es AUD 6.34M
¿Cuál es el último beneficio anual de Control Bionics?
El último beneficio anual de Control Bionics es AUD -5.91M
¿Cuál es la dirección registrada de Control Bionics?
La dirección registrada de Control Bionics es SUITE 5.01, LEVEL 5, 697 BURKE ROAD, MELBOURNE, VICTORIA, 3124
¿En qué sector industrial opera Control Bionics?
Control Bionics opera en el sector RADIOTELEPHONE COMMUNICATION

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ATHOAlterity Therapeutics Limited
AUD 0.012
(200.00%)
109.48M
ATHAlterity Therapeutics Ltd
AUD 0.018
(125.00%)
445.78M
NRZONeuRizer Ltd
AUD 0.002
(100.00%)
440k
VPRVolt Group Ltd
AUD 0.002
(100.00%)
5.01k
SFGSeafarms Group Limited
AUD 0.002
(100.00%)
132.21k
HYDHydrix Limited
AUD 0.015
(-31.82%)
1.92M
CNJConico Ltd
AUD 0.007
(-30.00%)
4.34M
FG1OFlynn Gold Limited
AUD 0.005
(-28.57%)
325.02k
MIOMacarthur Minerals Ltd
AUD 0.031
(-27.91%)
277.59k
ACWODActinogen Medical Limited
AUD 0.008
(-27.27%)
200k
ATHAlterity Therapeutics Ltd
AUD 0.018
(125.00%)
445.78M
ATHOAlterity Therapeutics Limited
AUD 0.012
(200.00%)
109.48M
ZIPZip Co Limited
AUD 2.44
(-25.15%)
80.5M
VFXVisionflex Group Ltd
AUD 0.0025
(-16.67%)
76.79M
EELENRG Elements Ltd
AUD 0.001
(0.00%)
76.35M
pegs1 pegs1 2 minutos hace
Test 🕵️
Thanks for the info!
CRTG
lovethatgreen lovethatgreen 9 minutos hace
Actually Marshall says a partner o another company he co founded has recieved a p1 project from a major defense contractor and will move to a phase 2 in Jan. He talks about the venture arm funding but its n o t clear who gets what exactly. The partner or moni or shieldcom or all 3
At the ve
MONI
Killmaril Killmaril 13 minutos hace
Manipulation here.. It´s done. Trumpet don´t like China. Ai manipulation with price... And many other stock...It sad..
TANH
jeunke22 jeunke22 17 minutos hace
https://www.linkedin.com/posts/cesarconda_pentagon-nationalsecurity-foreignpolicy-activity-7290508326080040960-U9h3?utm_source=share&utm_medium=member_android
NB
Plato_ Plato_ 18 minutos hace
Greetings, iamadog! You make great points. Thank you for them. I would like to expand on longevity and no dilution. VeeMost was founded in 2002 according to its https://veemost.com/about-veemost/ website . So, its longevity to date is about 23 years. VeeMost has been a public company for 2 years.
GDVM
gdl gdl 33 minutos hace
Middle of a despot's total control of this country and you only see profits. Like a pandemic declared and everyone ignored it. NO ONE can ever argue the facts on Trump, can they. they might approve or think it benefits them BUT not that he is a MONSTER.

Trump has 2 years to fix the
SPY
rbtree rbtree 38 minutos hace
Ummm, hate to break it to ya, but that is old news from over a year ago...

Meanwhile, this pig bounces between .000001 and .0001... does it even have a bid anymore?
KEGS
jeunke22 jeunke22 42 minutos hace
Just to prove that we need more low latency, bandwidth and speed …. This is the answer to a simple question:
“ Sorry, DeepSeek search service is busy. Please disable search or try again later.”
LWLG
gdl gdl 46 minutos hace
Not only has all 3 branches of government greedily abandoned their pledge they also have lost their souls. I warned, no insisted this was happening. it spells the end of our Republic and end of the stock market. no not for a year or 5 but for decades. The godlike Trump flexes and extends his muscl
RuudSaltis RuudSaltis 51 minutos hace
That’s why he needs only 6 months….! He has a razer sharp plan. It’s amazing how he communicates also one on one with shareholders…
LWLG
wagner wagner 51 minutos hace
I would bet no smart money in before the Exim in on stage... 
NB
Truenorth2016 Truenorth2016 54 minutos hace
Just a Reminder to you and anyone lurking, we just saw the Quantum Computing Healthcare stock RG*ti run from .66 cents to $21.00 in a few months. What people need to understand is GCAN already told us they are being approach by companies for a Quantum Computing /AI merger "BUT" I the CEO never told
GCAN
ramfan60 ramfan60 57 minutos hace
What's wrong with the wingnut? You must be happy with the wonderful job our FDA and NIH have done regulating our food and nutrition over the past 50 years. RFK is passionate about Making America Healthy Again......I'm all for it and he can't get confirmed fast enough as far as I'm concerned.
AMRN
ron_66271 ron_66271 1 hora hace
Thank for Supporting My Argument.

JPM didn’t have the money to cover Lehman’s ‘Market to Market’ of $17 Billion on September 14th.

Need more?

“BlackRock?”
Why…


All Classes are in the Money.



Ron
JPM
Zorax Zorax 1 hora hace
He's going to sell them shitface bibles.
Doc logic Doc logic 1 hora hace
exwannabe,

Simply put: Crossover to an active substance instead of placebo required that the active substance being utilized in the crossover be measured against a comparable group being treated with anything other than a known active substance. Comparators had to be changed when SO
NWBO
ron_66271 ron_66271 1 hora hace
CTS are in the Same Camp as Preferred Shares.

Securitized by Derivative Contracts.

You didn’t understand the Derivative Market Meltdown of 2008.

Lehman’s wasn’t the problem.
JPM was.



Ron
JPM
littlejohn littlejohn 1 hora hace
Traders who played other big names for

Wednesday could start back in

here on the cheapies...

META and MSFT make a lot of money...

And can spend on Ai - R and D...

Seems a good money flow watch...

so we watch..
MSFT
hbhmb hbhmb 1 hora hace
You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
AIAD
Wrangler1 Wrangler1 1 hora hace
Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
WDLF
Golfnut3 Golfnut3 1 hora hace
Thanks for the input...
ALYI
littlejohn littlejohn 2 horas hace
Fine idea, put sellers on 28 turned bullish

on Wednesday with big volume...

https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

those are willing share buyers at 28

if they get exercised with a close on
SMCI
trader53 trader53 2 horas hace
DPLS 0.0004 - Short Squeeze Soon!


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________


https://
DPLS MFI

Su Consulta Reciente

Delayed Upgrade Clock